[Glaucoma Treatment at Gangnam Station] The Silent Thief of Sight: A Complete Medical Guide to Glaucoma Treatments (Medication, Laser, Surgery)

Hello.

I am Dr. Jin-hyung Park, Chief Director of St. Mary's Jin Eye Clinic, dedicated to safeguarding your ocular health right in the heart of Gangnam-daero.

Glaucoma, widely known as the "silent thief of sight," causes virtually no noticeable symptoms in its early stages and is often diagnosed only after significant damage has occurred.

Many patients feel overwhelmed by the fear of blindness upon receiving a glaucoma diagnosis. However, advances in modern ophthalmology have yielded diverse, customized treatment options tailored to each individual's clinical status.

Today, for patients seeking specialized glaucoma treatment near Gangnam Station, I will comprehensively explain the three core categories of glaucoma management—medication, laser therapy, and surgical intervention—based on international clinical ophthalmic guidelines and the latest medical evidence.

Core Pathophysiology of Glaucoma: Intraocular Pressure and Aqueous Humor Dynamics. To fully grasp your treatment options, it is essential to first understand what causes glaucoma.

Inside our eyes, a clear fluid known as "aqueous humor" is continuously produced and drained to maintain structural shape and deliver vital nutrients.

If the outflow pathway for aqueous humor becomes obstructed or narrowed, intraocular pressure (IOP) increases, placing excessive pressure on the optic nerve and leading to irreversible damage.

You can observe the intricate anatomical structures of the eye and the location of the optic nerve in detail below.

Take a closer look at Schlemm's canal, through which aqueous humor flows, alongside the optic nerve head.

The ultimate goal of treatment is to reduce IOP to an individualized target level to halt or slow further optic nerve damage.

Depending on the clinical stage (early, moderate, or advanced) and specific type of glaucoma, treatments are administered sequentially or in combination.

Step 1: Medical Therapy (Eye Drops and Oral Medications)

The standard primary approach in glaucoma management is topical pharmacotherapy with eye drops.

Depending on baseline IOP and optic nerve status, a single agent or a combination of multiple medications may be prescribed.

Step 2: Laser Therapy

When medical therapy is poorly tolerated, fails to adequately reduce intraocular pressure, or when immediate decompression is needed for angle closure, laser procedures are performed.

These are brief outpatient procedures performed under topical anesthetic drops without requiring hospitalization.

Selective Laser Trabeculoplasty (SLT)

Mechanism: Delivers targeted laser energy to the trabecular meshwork—the eye’s natural drainage channel—to restore cellular drainage function without causing thermal collateral damage.

Advantages: Following landmark clinical investigations such as the LIGHT trial, SLT is now strongly endorsed as a safe, highly effective first-line therapy for early open-angle glaucoma, offering an alternative to eye drops.

It reduces the burden of daily drop regimens and minimizes ocular surface side effects.

Laser Peripheral Iridotomy (LPI)

Mechanism: Indicated for patients with acute or subacute angle-closure glaucoma, where the drainage angle is mechanically blocked.

A microscopic bypass opening is created in the peripheral iris using a specialized laser, allowing trapped aqueous humor to circulate into the anterior chamber and relieving pupil block.

Step 3: Surgical Intervention (Glaucoma Surgery)

Surgical intervention is indicated when maximal medical therapy and laser treatments fail to achieve target IOP, posing a continuous risk of irreversible optic nerve damage.

1. Traditional Glaucoma Surgery

Offers the most pronounced reduction in intraocular pressure, but demands advanced microsurgical skill and meticulous postoperative management.

Trabeculectomy: Regarded as the standard filtering surgery. A delicate scleral flap (window) is fashioned in the white of the eye, creating a subconjunctival drainage reservoir known as a "filtering bleb."

Antifibrotic agents such as Mitomycin-C (MMC) are applied intraoperatively to prevent scarring and maintain long-term bleb patency.

Glaucoma Tube Shunt Surgery (Aqueous Drainage Device): Indicated when trabeculectomy has failed or in refractory cases such as neovascular or uveitic glaucoma.

A microscopic medical-grade silicone tube with an integrated valve mechanism (such as the Ahmed Glaucoma Valve) is placed inside the anterior chamber to reliably shunt excess fluid out of the eye.

2. Minimally Invasive Glaucoma Surgery (MIGS)

MIGS represents one of the most innovative and rapidly advancing frontiers in modern ophthalmic surgery worldwide.

Mechanism and Advantages: Performed via an internal micro-incision without substantial dissection of external ocular tissues, inserting micro-scale biocompatible stents.

The procedure is fast, minimizes tissue trauma, enables remarkably swift recovery, and significantly reduces traditional surgical complications such as persistent hypotony.

Target Patients: Excellent for patients with mild-to-moderate glaucoma experiencing drop intolerance or poor compliance. Because it can be combined seamlessly with routine cataract surgery (phacoemulsification), both cataracts and elevated IOP can be addressed in a single session.

Prominent examples include iStent and Xen Gel Stent implantation.

Glaucoma Management at Gangnam Station: Dedicated, Continuous Follow-up Is Crucial.

Glaucoma is not a disorder that can be cured once and forgotten. It is a lifelong manageable condition where maintaining target pressure preserves remaining visual function.

Consequently, access to university hospital-grade diagnostic instruments coupled with clear physician-patient communication is paramount.

At St. Mary's Jin Eye Clinic, we deliver personalized medical care to patients in the Gangnam and Seocho districts by thoroughly evaluating individual corneal thickness, optic disc morphology, and personal lifestyles, offering a full spectrum of treatments spanning medical drops, SLT/LPI laser treatments, MIGS, and traditional incisional surgery.

Our dedicated clinic precisely measures your IOP, retinal nerve fiber layer thickness, visual fields, and corneal parameters to tailor the safest and most effective clinical trajectory for your eyes.

If you suspect glaucoma or require comprehensive, evidence-based pressure management, schedule a detailed consultation with us today.

Frequently Asked Questions

Can glaucoma be completely cured?

No, glaucoma cannot be cured. Because damaged optic nerve fibers cannot regenerate, treatment focuses on lifelong pressure management to maintain safe target levels and prevent further progressive vision loss.

What is the first-line treatment for early-stage glaucoma?

Topical medical therapy using ocular hypotensive drops is the standard primary approach. Depending on baseline pressure and optic nerve condition, prostaglandin analogs, beta-blockers, or combination drops are prescribed. Selective Laser Trabeculoplasty (SLT) is also widely utilized as an effective initial treatment.

What are the benefits of Selective Laser Trabeculoplasty (SLT)?

SLT is an outpatient procedure performed under topical anesthesia that selectively stimulates the trabecular meshwork to enhance aqueous drainage. It provides an effective alternative to daily eye drops, eliminating compliance issues and ocular surface adverse effects in early open-angle glaucoma.

Who is an ideal candidate for Minimally Invasive Glaucoma Surgery (MIGS)?

MIGS is well-suited for patients with mild-to-moderate glaucoma who struggle with drop side effects or inconsistent compliance. Performed through micro-incisions with minimal tissue trauma, MIGS can also be combined with standard cataract surgery for simultaneous vision and pressure improvement.

When is traditional trabeculectomy recommended?

Trabeculectomy is recommended for moderate-to-advanced or rapidly progressing glaucoma where target intraocular pressure cannot be reached through maximal medical therapy and laser intervention. It creates a surgical filtering bleb to achieve substantial and sustained pressure reduction.